Whyte, W. (2004) Assessing microbial risk to patients from aseptically manufactured pharmaceuticals. European Journal of Parenteral and Pharmaceutical Sciences, 9(3), pp. 71-77.
|
Text
86267.pdf - Published Version 106kB |
Abstract
The microbial risk to patients from aseptically manufactured pharmaceuticals is dependent on the chance that a product contains sufficient microbes to initiate an infection. This possibility is dependent on risk factors associated with the method of production and product formulation, and can be calculated. An analysis of these risk factors can be used to minimise patient risk and assist in determining the appropriate level of contamination control required for manufacturing.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Whyte, Dr William |
Authors: | Whyte, W. |
College/School: | College of Science and Engineering |
Journal Name: | European Journal of Parenteral and Pharmaceutical Sciences |
Publisher: | Euromed Communications Ltd. |
ISSN: | 0964-4679 |
ISSN (Online): | 1740-6277 |
Copyright Holders: | Copyright © 2004 The Pharmaceutical and Healthcare Sciences Society |
First Published: | First published in European Journal of Parenteral and Pharmaceutical Sciences 9(3):71-77 |
Publisher Policy: | Reproduced in accordance with the permission of the publisher. |
University Staff: Request a correction | Enlighten Editors: Update this record